PubMed

Artificial neural network (ANN) velocity better identifies benign prostatic hyperplasia but not prostate cancer compared with PSA velocity.

Stephan C, Büker N, Cammann H, Meyer HA, Lein M, Jung K.

BMC Urol. 2008 Sep 2;8:10.PMID: 18764937 [PubMed - indexed for MEDLINE]Related articlesFree article

In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL.

Kwiatkowski MK, Recker F, Piironen T, Pettersson K, Otto T, Wernli M, Tscholl R.

Urology. 1998 Sep;52(3):360-5.PMID: 9730444 [PubMed - indexed for MEDLINE]Related articles

Clinical utility of human glandular kallikrein 2 within a neural network for prostate cancer detection.

Stephan C, Jung K, Soosaipillai A, Yousef GM, Cammann H, Meyer H, Xu C, Diamandis EP.

BJU Int. 2005 Sep;96(4):521-7.PMID: 16104903 [PubMed - indexed for MEDLINE]Related articles

Three new serum markers for prostate cancer detection within a percent free PSA-based artificial neural network.

Stephan C, Xu C, Brown DA, Breit SN, Michael A, Nakamura T, Diamandis EP, Meyer H, Cammann H, Jung K.

Prostate. 2006 May 1;66(6):651-9.PMID: 16388506 [PubMed - indexed for MEDLINE]Related articles

Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.

Becker C, Piironen T, Pettersson K, Björk T, Wojno KJ, Oesterling JE, Lilja H.

J Urol. 2000 Jan;163(1):311-6.PMID: 10604382 [PubMed - indexed for MEDLINE]Related articles

Benign prostatic hyperplasia-associated free prostate-specific antigen improves detection of prostate cancer in an artificial neural network.

Stephan C, Cammann H, Deger S, Schrader M, Meyer HA, Miller K, Lein M, Jung K.

Urology. 2009 Oct;74(4):873-7. Epub 2009 May 24.PMID: 19476981 [PubMed - indexed for MEDLINE]Related articles

An artificial neural network to predict the outcome of repeat prostate biopsies.

Remzi M, Anagnostou T, Ravery V, Zlotta A, Stephan C, Marberger M, Djavan B.

Urology. 2003 Sep;62(3):456-60.PMID: 12946746 [PubMed - indexed for MEDLINE]Related articles

The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia.

Stephan C, Lein M, Jung K, Schnorr D, Loening SA.

Cancer. 1997 Jan 1;79(1):104-9.PMID: 8988733 [PubMed - indexed for MEDLINE]Related articlesFree article

Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsies.

Stephan C, Cammann H, Semjonow A, Diamandis EP, Wymenga LF, Lein M, Sinha P, Loening SA, Jung K.

Clin Chem. 2002 Aug;48(8):1279-87.PMID: 12142385 [PubMed - indexed for MEDLINE]Related articlesFree article

A [-2]proPSA-based artificial neural network significantly improves differentiation between prostate cancer and benign prostatic diseases.

Stephan C, Kahrs AM, Cammann H, Lein M, Schrader M, Deger S, Miller K, Jung K.

Prostate. 2009 Feb 1;69(2):198-207.PMID: 18942119 [PubMed - indexed for MEDLINE]Related articles

A (-5, -7) proPSA based artificial neural network to detect prostate cancer.

Stephan C, Meyer HA, Kwiatkowski M, Recker F, Cammann H, Loening SA, Jung K, Lein M.

Eur Urol. 2006 Nov;50(5):1014-20. Epub 2006 May 2.PMID: 16697520 [PubMed - indexed for MEDLINE]Related articles

[An artificial neural network as a tool in risk evaluation of prostate cancer. Indication for biopsy with the PSA range of 2-20 microg/l]

Stephan C, Vogel B, Cammann H, Lein M, Klevecka V, Sinha P, Kristiansen G, Schnorr D, Jung K, Loening SA.

Urologe A. 2003 Sep;42(9):1221-9. Epub 2003 Mar 22. German. PMID: 14504755 [PubMed - indexed for MEDLINE]Related articles

[Usefulness of the percentage of free prostatic specific antigen in the differential diagnosis between benign prostatic hyperplasia and prostate cancer]

Gaspar MJ, Arribas I, Hontoria JM, Bokobo P, Coca C, Angulo JC.

Med Clin (Barc). 2000 Sep 23;115(9):332-6. Spanish. PMID: 11093893 [PubMed - indexed for MEDLINE]Related articles

[Changes of serum total PSA and free PSA in patients with prostate carcinoma and benign prostate hyperplasia]

Gao ZW, Liu G, Sheng BW.

Ai Zheng. 2004 Jun;23(6):701-3. Chinese. PMID: 15191675 [PubMed - indexed for MEDLINE]Related articlesFree article

An artificial neural network for five different assay systems of prostate-specific antigen in prostate cancer diagnostics.

Stephan C, Cammann H, Meyer HA, Müller C, Deger S, Lein M, Jung K.

BJU Int. 2008 Sep;102(7):799-805. Epub 2008 Jun 3.PMID: 18522632 [PubMed - indexed for MEDLINE]Related articles

Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).

Wolters T, Roobol MJ, Bangma CH, Schröder FH.

Eur Urol. 2009 Feb;55(2):385-92. Epub 2008 Mar 11.PMID: 18353529 [PubMed - indexed for MEDLINE]Related articles

Comparison of two different artificial neural networks for prostate biopsy indication in two different patient populations.

Stephan C, Xu C, Finne P, Cammann H, Meyer HA, Lein M, Jung K, Stenman UH.

Urology. 2007 Sep;70(3):596-601. Epub 2007 Aug 3.PMID: 17688922 [PubMed - indexed for MEDLINE]Related articles

Progression of prostate cancer: diagnostic and prognostic utility of prostate-specific antigen, alpha2-macroglobulin, and their complexes.

Kanoh Y, Ohtani N, Ohara T, Mashiko T, Ohtani S, Egawa S, Baba S, Ohtani H.

Oncol Rep. 2001 May-Jun;8(3):515-9.PMID: 11295072 [PubMed - indexed for MEDLINE]Related articles

Diagnostic efficacy of free to total ratio of prostate-specific antigen and prostate-specific antigen velocity, singly and in combination, in detecting prostate cancer in patients with total serum prostate-specific antigen between 4 and 10 ng/ml.

Yamamoto S, Maruyama T, Kondoh N, Nojima M, Takiuchi H, Hirota S, Shima H.

Int Urol Nephrol. 2008;40(1):85-9. Epub 2007 Jul 6.PMID: 17619162 [PubMed - indexed for MEDLINE]Related articles

[Usefulness of PSA and its fractions in the diagnosis of prostate cancer]

Filella X, Truan D, Alcover J, Molina R, Luque P, Coca F, Ballesta AM.

Med Clin (Barc). 2004 Feb 28;122(7):241-4. Spanish. PMID: 15012870 [PubMed - indexed for MEDLINE]Related articles